Access cutting-edge hepatocellular carcinoma treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access hepatocellular carcinoma specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hepatocellular carcinoma treatment provided free
Open-label, uncontrolled, phase 1-2 study to evaluate the safety, tolerability, pharmacodynamic effects, and preliminary efficacy of ABX196 administered in combination with nivolumab in patients with hepatocellular carcinoma
Sponsor: Abivax S.A.
Check if you qualify for this hepatocellular carcinoma clinical trial in Houston, TX
If you're searching for hepatocellular carcinoma treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatocellular carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.